Otello Stampacchia Buys $29.8M of Windward BIO Group Ag (WWB) — SEC Form 4, Nov 18, 2026
Equity Position
5.34M sh
0 → 5,338,520
Insider Cluster
4 buying
within 30 days — view cluster
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Otello Stampacchia CIK 0001361712 |
Director
|
Otello Stampacchia at Windward BIO Group Ag
Full insider history
Bought (12 mo)
$29,750,000
Sold (12 mo)
—
More from this insider at Windward BIO Group Ag
| 2026-11-16 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common SharesF1 | 2026-11-16 | P - Purchase | 875,000 A | $17.00 | +$14,875,000 | 875,000 | Indirect By Omega Fund VII, L.P. |
| Common SharesF2 | 2026-11-16 | P - Purchase | 875,000 A | $17.00 | +$14,875,000 | 875,000 | Indirect By Omega Fund VIII, L.P. |
| Common SharesF3F1 | 2026-11-16 | C - Conversion | 1,262,628 A | — | 2,137,628 | Indirect By Omega Fund VII, L.P. | |
| Common SharesF3F2 | 2026-11-16 | C - Conversion | 1,262,626 A | — | 2,137,626 | Indirect By Omega Fund VIII, L.P. | |
| Common SharesF3F1 | 2026-11-16 | C - Conversion | 531,632 A | — | 2,669,260 | Indirect By Omega Fund VII, L.P. | |
| Common SharesF3F2 | 2026-11-16 | C - Conversion | 531,634 A | — | 2,669,260 | Indirect By Omega Fund VIII, L.P. |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Series A Preferred SharesF3F3F3F1 | 2026-11-16 | C - Conversion | 1,262,628 D | $0.00 | 1,262,628 Common Shares | Indirect By Omega Fund VII, L.P. | ||
| Series A Preferred SharesF3F3F3F2 | 2026-11-16 | C - Conversion | 1,262,626 D | $0.00 | 1,262,626 Common Shares | Indirect By Omega Fund VIII, L.P. | ||
| Series B Preferred SharesF3F3F3F1 | 2026-11-16 | C - Conversion | 531,632 D | $0.00 | 531,632 Common Shares | Indirect By Omega Fund VII, L.P. | ||
| Series B Preferred SharesF3F3F3F2 | 2026-11-16 | C - Conversion | 531,634 D | $0.00 | 531,634 Common Shares | Indirect By Omega Fund VIII, L.P. |
Footnotes (3)
- F1
- Shares held directly by Omega Fund VII, L.P. ("Omega VII"). Omega Fund VII GP, L.P. ("Omega VII GP") is the sole general partner of Omega VII. Omega Fund VII GP Manager, Ltd. ("Omega VII Manager") is the sole general partner of Omega VII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VII Manager and each disclaims beneficial ownership of the shares held by Omega VII except to the extent of his pecuniary interest therein, if any. Show more
- F2
- Shares held directly by Omega Fund VIII, L.P. ("Omega VIII"). Omega Fund VIII GP, L.P. ("Omega VIII GP") is the sole general partner of Omega VIII. Omega Fund VIII GP Manager, Ltd. ("Omega VIII Manager") is the sole general partner of Omega VIII GP. The Reporting Person, Claudio Nessi and Francesco Draetta are the directors of Omega VIII Manager and each disclaims beneficial ownership of the shares held by Omega VIII except to the extent of his pecuniary interest therein, if any. Show more
- F3
- Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1 to 1 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date. Show more
Related filings at Windward BIO Group Ag
Other insiders at Windward BIO Group Ag
GET /v1/forms/4/0001361712-26-000011
API docs
View Original SEC Filing